Matthew Rosebraugh

Title: Matthew Rosebraugh: Innovator in Pharmaceutical Formulations

Introduction

Matthew Rosebraugh is a notable inventor based in Grayslake, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative approach focuses on the formulation of specific compounds that can be administered subcutaneously.

Latest Patents

Matthew holds a patent for "Pharmaceutical formulations for subcutaneous administration." This patent details compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which have a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through the subcutaneous administration of these compositions. He has 1 patent to his name.

Career Highlights

Throughout his career, Matthew has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Matthew has collaborated with esteemed professionals in his field, including Ehab Moussa and Feroz Jameel. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Matthew Rosebraugh is a dedicated inventor whose work in pharmaceutical formulations has the potential to significantly impact the treatment of Parkinson's disease. His innovative contributions and collaborations highlight his commitment to advancing medical science.